Sun Pharmaceutical Industries Reports Mixed Stock Performance Amid Sector Outperformance

Sun Pharmaceutical Industries has shown notable activity today, outperforming its sector by 0.26%. The stock opened at Rs 1662.2 and has maintained this price throughout the trading session. In terms of moving averages, the stock is currently above the 5-day, 20-day, 50-day, and 100-day averages, although it remains below the 200-day moving average.
With a market capitalization of Rs 3,96,094.21 crore, Sun Pharmaceutical operates within the Pharmaceuticals & Biotechnology industry, where it holds a P/E ratio of 34.60, slightly below the industry average of 35.11.

Over the past year, the stock has experienced a decline of 12.95%, contrasting with the Sensex's gain of 1.77%. In the short term, the stock has seen a decrease of 0.19% today, a 0.45% drop over the past week, and a modest increase of 2.48% over the past month. Year-to-date, the stock is down 12.40%, while it has shown strong performance over longer periods, with a 69.17% increase over three years and a remarkable 239.09% rise over five years.